Literature DB >> 28061386

Characterization of the disassembly and reassembly of the HBV glycoprotein surface antigen, a pliable nanoparticle vaccine platform.

John R Gallagher1, Udana Torian1, Dustin M McCraw1, Audray K Harris2.   

Abstract

While nanoparticle vaccine technology is gaining interest due to the success of vaccines like those for the human papillomavirus that is based on viral capsid nanoparticles, little information is available on the disassembly and reassembly of viral surface glycoprotein-based nanoparticles. One such particle is the hepatitis B virus surface antigen (sAg) that exists as nanoparticles. Here we show, using biochemical analysis coupled with electron microscopy, that sAg nanoparticle disassembly requires both reducing agent to disrupt intermolecular disulfide bonds, and detergent to disrupt hydrophobic interactions that stabilize the nanoparticle. Particles were otherwise resistant to salt and urea, suggesting the driving mechanism of particle formation involves hydrophobic interactions. We reassembled isolated sAg protein into nanoparticles by detergent removal and reassembly resulted in a wider distribution of particle diameters. Knowledge of these driving forces of nanoparticle assembly and stability should facilitate construction of epitope-displaying nanoparticles that can be used as immunogens in vaccines. Published by Elsevier Inc.

Entities:  

Keywords:  Assembly; Disassembly; Electron microscopy; Glycoprotein nanoparticles; HBV surface antigen; Reassembly; Tomography; Vaccines; Virus structure

Mesh:

Substances:

Year:  2017        PMID: 28061386      PMCID: PMC5276716          DOI: 10.1016/j.virol.2016.12.025

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  53 in total

1.  Processing of hepatitis B virus surface proteins.

Authors:  Volker Bruss
Journal:  Methods Mol Med       Date:  2004

Review 2.  Structure of complex viruses and virus-infected cells by electron cryo tomography.

Authors:  Kay Grünewald; Marek Cyrklaff
Journal:  Curr Opin Microbiol       Date:  2006-07-10       Impact factor: 7.934

3.  Native hepatitis B virions and capsids visualized by electron cryomicroscopy.

Authors:  Kelly A Dryden; Stefan F Wieland; Christina Whitten-Bauer; John L Gerin; Francis V Chisari; Mark Yeager
Journal:  Mol Cell       Date:  2006-06-23       Impact factor: 17.970

Review 4.  Electron tomography of viruses.

Authors:  Sriram Subramaniam; Alberto Bartesaghi; Jun Liu; Adam E Bennett; Rachid Sougrat
Journal:  Curr Opin Struct Biol       Date:  2007-10-25       Impact factor: 6.809

5.  Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs).

Authors:  Henryk Mach; David B Volkin; Robert D Troutman; Bei Wang; Zheng Luo; Kathrin U Jansen; Li Shi
Journal:  J Pharm Sci       Date:  2006-10       Impact factor: 3.534

6.  Antibody responses to recombinant and plasma derived hepatitis B vaccines.

Authors:  S E Brown; C Stanley; C R Howard; A J Zuckerman; M W Steward
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-18

7.  Calcium is required in reassembly of bovine papillomavirus in vitro.

Authors:  J Paintsil; M Müller; M Picken; L Gissmann; J Zhou
Journal:  J Gen Virol       Date:  1998-05       Impact factor: 3.891

8.  Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis.

Authors:  M E Bayer; B S Blumberg; B Werner
Journal:  Nature       Date:  1968-06-15       Impact factor: 49.962

9.  Subtyping of hepatitis B surface antigen and antibody by radioimmunoassay.

Authors:  J H Hoofnagle; R J Gerety; L A Smallwood; L F Barker
Journal:  Gastroenterology       Date:  1977-02       Impact factor: 22.682

10.  Cryo-electron microscopy of hepatitis B virions reveals variability in envelope capsid interactions.

Authors:  Stefan Seitz; Stephan Urban; Christoph Antoni; Bettina Böttcher
Journal:  EMBO J       Date:  2007-08-30       Impact factor: 11.598

View more
  6 in total

1.  Structural analysis of influenza vaccine virus-like particles reveals a multicomponent organization.

Authors:  Dustin M McCraw; John R Gallagher; Udana Torian; Mallory L Myers; Michael T Conlon; Neetu M Gulati; Audray K Harris
Journal:  Sci Rep       Date:  2018-07-09       Impact factor: 4.379

Review 2.  Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy.

Authors:  John R Gallagher; Dustin M McCraw; Udana Torian; Neetu M Gulati; Mallory L Myers; Michael T Conlon; Audray K Harris
Journal:  Vaccines (Basel)       Date:  2018-05-25

Review 3.  Role of Multivalency and Antigenic Threshold in Generating Protective Antibody Responses.

Authors:  Mark K Slifka; Ian J Amanna
Journal:  Front Immunol       Date:  2019-05-01       Impact factor: 8.786

4.  Comparative purification and characterization of hepatitis B virus-like particles produced by recombinant vaccinia viruses in human hepatoma cells and human primary hepatocytes.

Authors:  Edith Reuschel; Wolfgang Jilg; Birgit Seelbach-Goebel; Ludwig Deml
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

5.  A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response.

Authors:  Arianna Marini; Yu Zhou; Yuanyuan Li; Iona J Taylor; Darren B Leneghan; Jing Jin; Marija Zaric; David Mekhaiel; Carole A Long; Kazutoyo Miura; Sumi Biswas
Journal:  Front Immunol       Date:  2019-12-12       Impact factor: 7.561

Review 6.  Designs of Antigen Structure and Composition for Improved Protein-Based Vaccine Efficacy.

Authors:  Kyle Saylor; Frank Gillam; Taylor Lohneis; Chenming Zhang
Journal:  Front Immunol       Date:  2020-02-24       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.